number of cases was 137236, including 6 active cases, 135110 recoveries and 2120 deaths. there hasn't been any covid related death in the region in more than 2 months. as of 9 june, the total number of cases was 137242, including 1 active case, 135121 cures and 2120 deaths. as of 16 june, the total number of cases was 137244, including 2 active cases, 135122 cures and 2120 fatal cases. july to september 2022 as of 8 july, the total number of cases in manipur was 137389, including 117 active cases, 135151 cures and 2120 deaths. there hasn't been any covid related death in the region in more than a quarter. as of 26 august, the total number of cases was 139671, including 86 active cases, 137439 recoveries and 2146 deaths. as of 31 august, the total number of cases was 139709, including 67 active cases, 137495 cures and 2147 fatal cases. as of 10 september, the total number of cases was 139755, including 27 active cases, 137580 recoveries and 2148 fatal cases. as of 24 september, the total number of cases was 139805, including 27 active cases, 137630 cures and 2148 deaths. as of 26 october, the total number of cases was 139871, including 22 active cases, 137700 recoveries and 2149 deaths. 2023 as of 22 march 2023, the total number of cases in manipur was 139924, including no active case, 137775 cures and 2149 deaths. covid-19 vaccines with approval for emergency or conditional usage union minister for health & family welfare, dr. harsh vardhan visiting the gtb hospital, shahdara to review the preparedness of dry run of covid-19 vaccine, in delhi on january 02, 2021. main article: covid-19 vaccine covishield on january 1, 2021, the drug controller general of india, approved the emergency or conditional use of astrazeneca's covid-19 vaccine azd1222 (marketed as covishield). covishield is developed by the university of oxford and its spin-out company, vaccitech. it's a viral vector vaccine based on replication-deficient adenovirus that causes cold in chimpanzees. it can be stored, transported and handled at normal refrigerated conditions (two-eight degrees celsius/ 36-46 degrees fahrenheit). it has a shelf-life of at least six months. on 12 january 2021 first batches of covishield vaccine was despatched from the serum institute of india. covaxin on january 2, 2021, bbv152 (marketed as covaxin), first indigenous vaccine, developed by bharat biotech in association with the indian council of medical research and national institute of virology received approval from the drug controller general of india for its emergency or conditional usage. on 14 january 2021 first batches of covaxin vaccine was despatched from the bharat biotech, albeit it was still in the third phase of testing. others on 19 may 2021, dr reddy's labs received emergency use authorisation for anti-covid drug 2-dg. on 21 february, 2022, drugs controller general of india granted approval to biological e's covid-19 vaccine corbevax, that can be used for children between 12 and 18 years of age. on 21 october 2021, india completed administering of one billion covid vaccines in the country. on 8 january 2022, india crossed 1.5 billion covid vaccines milestone in the country. on 19 february 2022, india crossed 1.75 billion covid vaccines milestone in the country.